BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22705008)

  • 1. Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus.
    Park SH; Shin EC; Capone S; Caggiari L; De Re V; Nicosia A; Folgori A; Rehermann B
    Gastroenterology; 2012 Oct; 143(4):1048-60.e4. PubMed ID: 22705008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
    Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
    Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
    Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.
    Swadling L; Capone S; Antrobus RD; Brown A; Richardson R; Newell EW; Halliday J; Kelly C; Bowen D; Fergusson J; Kurioka A; Ammendola V; Del Sorbo M; Grazioli F; Esposito ML; Siani L; Traboni C; Hill A; Colloca S; Davis M; Nicosia A; Cortese R; Folgori A; Klenerman P; Barnes E
    Sci Transl Med; 2014 Nov; 6(261):261ra153. PubMed ID: 25378645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
    Tan WG; Zubkova I; Kachko A; Wells F; Adler H; Sutter G; Major ME
    PLoS One; 2017; 12(7):e0181578. PubMed ID: 28732046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signatures of protective memory immune responses during hepatitis C virus reinfection.
    Abdel-Hakeem MS; Bédard N; Murphy D; Bruneau J; Shoukry NH
    Gastroenterology; 2014 Oct; 147(4):870-881.e8. PubMed ID: 25038432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8
    Peña-Asensio J; Calvo H; Torralba M; Miquel J; Sanz-de-Villalobos E; Larrubia JR
    Cells; 2021 Mar; 10(3):. PubMed ID: 33802622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity.
    Rollier CS; Paranhos-Baccala G; Verschoor EJ; Verstrepen BE; Drexhage JA; Fagrouch Z; Berland JL; Komurian-Pradel F; Duverger B; Himoudi N; Staib C; Meyr M; Whelan M; Whelan JA; Adams VC; Larrea E; Riezu JI; Lasarte JJ; Bartosch B; Cosset FL; Spaan WJ; Diepolder HM; Pape GR; Sutter G; Inchauspe G; Heeney JL
    Hepatology; 2007 Mar; 45(3):602-13. PubMed ID: 17326154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.
    Bengsch B; Spangenberg HC; Kersting N; Neumann-Haefelin C; Panther E; von Weizsäcker F; Blum HE; Pircher H; Thimme R
    J Virol; 2007 Jan; 81(2):945-53. PubMed ID: 17079288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral.
    Callendret B; Eccleston HB; Satterfield W; Capone S; Folgori A; Cortese R; Nicosia A; Walker CM
    Hepatology; 2016 May; 63(5):1442-54. PubMed ID: 26513111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
    Forns X; Payette PJ; Ma X; Satterfield W; Eder G; Mushahwar IK; Govindarajan S; Davis HL; Emerson SU; Purcell RH; Bukh J
    Hepatology; 2000 Sep; 32(3):618-25. PubMed ID: 10960458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation.
    Zubkova I; Choi YH; Chang E; Pirollo K; Uren T; Watanabe H; Wells F; Kachko A; Krawczynski K; Major ME
    Vaccine; 2009 Apr; 27(19):2594-602. PubMed ID: 19428866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.
    Radziewicz H; Ibegbu CC; Fernandez ML; Workowski KA; Obideen K; Wehbi M; Hanson HL; Steinberg JP; Masopust D; Wherry EJ; Altman JD; Rouse BT; Freeman GJ; Ahmed R; Grakoui A
    J Virol; 2007 Mar; 81(6):2545-53. PubMed ID: 17182670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model.
    Lukens JR; Cruise MW; Lassen MG; Hahn YS
    J Immunol; 2008 Apr; 180(7):4875-84. PubMed ID: 18354211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus clearance correlates with HLA-DR expression on proliferating CD8+ T cells in immune-primed chimpanzees.
    Zubkova I; Duan H; Wells F; Mostowski H; Chang E; Pirollo K; Krawczynski K; Lanford R; Major M
    Hepatology; 2014 Mar; 59(3):803-13. PubMed ID: 24123114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1(+)/CD127(-) HCV-specific CD8(+) cells targeting the virus in chronic hepatitis C virus infection.
    Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; González-Praetorius A; Albertos S; García-Garzón S; Lokhande M; Parra-Cid T
    Cell Immunol; 2011; 269(2):104-14. PubMed ID: 21481848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.
    Penna A; Pilli M; Zerbini A; Orlandini A; Mezzadri S; Sacchelli L; Missale G; Ferrari C
    Hepatology; 2007 Mar; 45(3):588-601. PubMed ID: 17326153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee.
    Youn JW; Park SH; Lavillette D; Cosset FL; Yang SH; Lee CG; Jin HT; Kim CM; Shata MT; Lee DH; Pfahler W; Prince AM; Sung YC
    Hepatology; 2005 Dec; 42(6):1429-36. PubMed ID: 16317673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.